Health News

No Need to Fear Lupus Medications
Fear that the treatment for one condition might cause another condition, like cancer, could prevent people from taking needed medications. But should this be a concern for lupus patients?
Battling Fatigue Decades Later
Being tired after any type of cancer therapy is to be expected. Some survivors of childhood cancer, though, can still be battling fatigue many years later.
Closing In on a Cure
Someone diagnosed with any type of leukemia in the early 1960s had about a 14 percent chance of being alive five years later. Today, those chances are vastly greater. 
Cancer Rx Granted Accelerated FDA Approval Path
The US Food and Drug Administration has given ibrutinib an accelerated pathway to approval. Ibrutinib is an investigational drug designed to treat two lymphomas.
New Vaccine Recommendation for Adults
Adults with certain immune system conditions often require different recommendations for the vaccines they can and should receive. A new vaccine has been added to these recommendations.
One Rx Better Than Another For Melanoma?
Two medications are approved in the US to treat advanced melanoma. Zelboraf ( vemurafenib ) was approved in September, 2012. DTIC-Dome ( dacarbazine ) is used to treat Hodgkin's lymphoma as well as melanoma. Which is the better medication?
The Wild Card in Lymphoma
Cancer in one person can behave very differently than it might in another person. That’s because each person’s genes are unique. So some new cancer treatments can target the individual’s unique genetic fingerprint. Scientists are exploring possible new targets in lymphoma.
Rx Shortages Affecting Kids With Cancer
There has been a shortage of certain medications for about three years now. Particularly hard hit have been generic injectable drugs. The shortage of one medication has affected kids with cancer.
Experimental Blood Cancer Rx is Showing Positive Results
There is excellent news for people with mantle cell lymphoma, a rare blood cancer. An experimental drug is demonstrating impressive results in a phase II clinical trial. But this is a limited research study, and the product is not yet available.
Cheers Against Blood Cancers
You’ve probably heard that red wine is good for you. And maybe you’ve also heard that drinking can increase your risks of specific types of cancer. A recent review puts a checkmark in the “alcohol-healthy” column.